NCT07215871View on ClinicalTrials.gov

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

September 29, 2026

Study Completion Date

September 29, 2027

Conditions
Influenza InfectionInfectionsRespiratory Virus InfectionsRespiratory Tract InfectionsRNA VirusesOrthomyxoviridae InfectionsViral Diseases
Interventions
BIOLOGICAL

A/Mallard/Ohio-99/MM4/1989 H10N7

Low pathogenicity avian influenza virus H10N7

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH